Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Equity Ratio (2016 - 2025)

Nephros has reported Equity Ratio over the past 16 years, most recently at 0.75 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.75 for Q4 2025, down 2.34% from a year ago — trailing twelve months through Dec 2025 was 0.75 (down 2.34% YoY), and the annual figure for FY2025 was 0.75, down 2.34%.
  • Equity Ratio for Q4 2025 was 0.75 at Nephros, down from 0.76 in the prior quarter.
  • Over the last five years, Equity Ratio for NEPH hit a ceiling of 0.87 in Q1 2021 and a floor of 0.7 in Q4 2023.
  • Median Equity Ratio over the past 5 years was 0.8 (2023), compared with a mean of 0.8.
  • Biggest five-year swings in Equity Ratio: increased 16.22% in 2021 and later decreased 14.31% in 2024.
  • Nephros' Equity Ratio stood at 0.84 in 2021, then fell by 3.37% to 0.81 in 2022, then fell by 12.73% to 0.7 in 2023, then grew by 8.68% to 0.77 in 2024, then dropped by 2.34% to 0.75 in 2025.
  • The last three reported values for Equity Ratio were 0.75 (Q4 2025), 0.76 (Q3 2025), and 0.78 (Q2 2025) per Business Quant data.